Sweden Achieves 18-Year Ahead of Schedule Smoke-Free Target

Dec.08.2022
Sweden Achieves 18-Year Ahead of Schedule Smoke-Free Target
Sweden achieves smoking rate of 5.6%, becoming the only European country to reach EU's no smoking goal ahead of schedule.

Swedish authorities have officially confirmed that the smoking rate in Sweden has now decreased to 5.6%. This makes Sweden the only European country to be on track to achieving the EU's goal of becoming smoke-free, achieving this target 18 years ahead of the 2040 deadline.


At an event organized by the Stockholm Snus Nicotine Committee, participants evaluated Sweden's incredible achievements and leadership in the fight against smoking. The country is on track to become the world's first to be defined as "smoke-free" and have a smoking population of less than 5%.


Since the 1980s, Sweden has achieved a remarkable feat unmatched by any other country in the world, reducing its smoking rate from 35% to less than 6%. The country now boasts the second lowest smoking rate in Europe, which is only half that of the next lowest country. In contrast, the average smoking rate in the EU is around 23%, which is four times higher than Sweden's. Notably, Europe also has the lowest tobacco-related death rate in the world.


On November 30, 2022, a group of leading public health experts, consumer advocates, and harm reduction professionals celebrated this achievement in Stockholm and once again called on policymakers around the world to ensure the availability of less harmful smoking alternatives as aids for quitting smoking.


Delon Human, President and Stockholm event organizer of Health Diplomats, stated during the event that if all 1.1 billion smokers worldwide were to switch to a less harmful nicotine replacement product, it could prevent disease and save millions of lives globally. Sweden has found a solution for smokers and we must work together to follow their example and save lives around the world.


This incredible success story sheds light on Sweden's secret to success, where the key factor is an open-minded attitude towards less harmful alternatives to smoking. While snus has long been at the forefront of harm reduction efforts, in recent years, nicotine pouches and e-cigarettes have become another valuable tool for Swedish smokers looking to quit.


Sweden's gradual harm reduction approach differs significantly from the measures proposed by the International Tobacco Control Organization. Advocates for harm reduction in the EU have been pushing for reductions in harm to be included in cancer prevention plans. Despite the fact that the Tobacco Control Framework Convention recognizes harm reduction as a viable option, the World Health Organization continues to refuse to acknowledge its benefits.


Professor Karl Fagerström stated during the event, "Sweden's upcoming presidency of the European Union is a great opportunity to share the country's successful stories, which accounts for 5% of the EU, with other member countries. We hope that Sweden will generously share this knowledge with other nations.


Speakers at the conference emphasized the need for evidence-based and comprehensive tobacco control policies. Therefore, it is imperative to implement the concept of reducing tobacco harm on a broader level to support smoking cessation.


Ensuring that the smoking alternatives with lower health risks are inexpensive, accessible, and easy to use, is a crucial prerequisite for Sweden's success in replicating it in other countries.


The Nicotine Oral Committee is a global nonprofit organization dedicated to assisting governments, health officials, and the public in building knowledge about nicotine oral products, challenging unfounded biases and stereotypes. The organization deals with political, scientific, consumer matters, and related product innovations. Their views are independent of any brand/manufacturer and are tailored to the individual and population health needs of adult smokers.


2FIRSTS will continue to follow and report on this topic. Updates will be available on the 2FIRSTS app. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03